Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.47% |
| 2 | Technology | 16.84% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.18% |
| 5 | Financials | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Petco
WOOF
$802M
| $1.61M | ﹤0.01% |
109,400
-95,000
| -46% | -$1.72M |
|
2352
Crinetics Pharmaceuticals
CRNX
$8.98B
| $1.61M | ﹤0.01% |
+86,400
| New | +$1.72M |
|
|
SOVO
2353
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $1.61M | ﹤0.01% |
101,500
+9,500
| +10% | +$138K |
|
2354
Teekay Tankers
TNK
$2.93B
| $1.61M | ﹤0.01% |
91,300
+74,100
| +431% | +$1.32M |
|
2355
Cimpress
CMPR
$2.35B
| $1.61M | ﹤0.01% |
+41,300
| New | +$2.01M |
|
2356
Norwood Financial Corp
NWFL
$378M
| $1.61M | ﹤0.01% |
66,225
-1,200
| -2% | -$31.8K |
|
2357
Ligand Pharmaceuticals
LGND
$5.78B
| $1.6M | ﹤0.01% |
+28,844
| New | +$1.64M |
|
2358
Everspin Technologies
MRAM
$442M
| $1.6M | ﹤0.01% |
305,906
+36,100
| +13% | +$232K |
|
2359
Cardiff Oncology
CRDF
$77.2M
| $1.6M | ﹤0.01% |
727,616
+236,158
| +48% | +$396K |
|
|
DRRX
2360
DELISTED
DURECT Corp
DRRX
| $1.6M | ﹤0.01% |
334,384
-15,644
| -4% | -$74.7K |
|
|
CASA
2361
DELISTED
Casa Systems, Inc. Common Stock
CASA
| $1.6M | ﹤0.01% |
406,200
+22,104
| +6% | +$96.3K |
|
2362
Helios Technologies
HLIO
$2.72B
| $1.59M | ﹤0.01% |
24,075
+12,700
| +112% | +$881K |
|
2363
Peoples Financial Services
PFIS
$716M
| $1.59M | ﹤0.01% |
28,481
-3,986
| -12% | -$203K |
|
|
BZUN
2364
Baozun
BZUN
$167M
| $1.59M | ﹤0.01% |
145,216
-114,232
| -44% | -$1M |
|
2365
loanDepot
LDI
$308M
| $1.58M | ﹤0.01% |
1,100,305
+310,820
| +39% | +$839K |
|
2366
Vaxcyte
PCVX
$8.59B
| $1.58M | ﹤0.01% |
72,600
+31,800
| +78% | +$736K |
|
2367
MillerKnoll
MLKN
$1.62B
| $1.58M | ﹤0.01% |
60,121
+40,721
| +210% | +$1.23M |
|
|
AAMI
2368
Acadian Asset Management
AAMI
$3.29B
| $1.58M | ﹤0.01% |
+87,700
| New | +$1.8M |
|
|
RNAM
2369
DELISTED
Avidity Biosciences
RNAM
| $1.57M | ﹤0.01% |
108,300
+69,900
| +182% | +$1.04M |
|
|
FGH
2370
DELISTED
FG Group Holdings Inc.
FGH
| $1.57M | ﹤0.01% |
652,012
-32,300
| -5% | -$93.2K |
|
2371
Kingstone Companies
KINS
$284M
| $1.57M | ﹤0.01% |
398,177
-13,012
| -3% | -$59K |
|
|
SBT
2372
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $1.56M | ﹤0.01% |
274,528
-51,378
| -16% | -$336K |
|
2373
Matthews International
MATW
$721M
| $1.56M | ﹤0.01% |
54,453
-16,100
| -23% | -$492K |
|
2374
Great Elm Group
GEG
$67.4M
| $1.56M | ﹤0.01% |
725,376
-6,000
| -0.8% | -$12K |
|
2375
AtaiBeckley Inc
ATAI
$2.7B
| $1.56M | ﹤0.01% |
428,200
+29,958
| +8% | +$122K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.